August 8, 2024
TOPLINE: Dupilumab remained effective in most patients with atopic dermatitis (AD) up to 5 years, although nearly a quarter of patients in the cohort study discontinued […]
August 8, 2024
TOPLINE: The maternal and neonatal outcomes in pregnant women treated with anti–interleukin (IL)-6 therapy for COVID-19 are largely favorable, with transient neonatal cytopenia observed in around […]
August 8, 2024
A recent cross-sectional study involving 804 volunteers and data from the 2016 National Health and Nutrition Survey found a high prevalence of metabolic syndrome among Mexican […]
August 8, 2024
Social media’s effects on the mental health of young people are not well understood. That hasn’t stopped Congress, state legislatures, and the US Surgeon General from […]
August 8, 2024
TOPLINE: In patients with skin or lung cancer, drugs that inhibit BRAF (v-raf murine sarcoma viral oncogene homolog B) mutations increase the risk for uveitis dramatically compared […]
August 8, 2024
For Immediate Release: August 07, 2024 Today, the U.S. Food and Drug Administration approved Zurnai, the first nalmefene hydrochloride auto-injector for the emergency treatment of known […]
August 7, 2024
Share on PinterestTo address the GLP-1 drug shortages, manufacturer Eli Lilly has ramped up production of Mounjaro and Zepbound. Scott Olson/Getty Images Zepbound and Mounjaro have […]
August 7, 2024
What are the possible side effects (results of trials used to assess safety)? Table 6 summarizes the adverse reactions in the 339 patients who received TALVEY […]
August 7, 2024
HOW TO USE THIS SNAPSHOT The information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630
Next page